NCT06943781

Brief Summary

This is a prospective study designed to compare the performance of fecal H. pylori gastric cancer susceptibility analysis and the gastric cancer risk questionnaire for the early detection of gastric cancer. The primary objective is to assess whether each method, individually or in combination, can facilitate earlier diagnosis of gastric cancer. All participants will undergo fecal H. pylori gastric cancer susceptibility testing and complete the gastric cancer risk questionnaire.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15,000

participants targeted

Target at P75+ for all trials

Timeline
20mo left

Started Jul 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress34%
Jul 2025Dec 2027

First Submitted

Initial submission to the registry

March 17, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 24, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

February 25, 2026

Status Verified

February 1, 2026

Enrollment Period

2 years

First QC Date

March 17, 2025

Last Update Submit

February 23, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Sensitivity and specificity of fecal H. pylori gastric cancer susceptibility testing and questionnaire for gastric cancer

    To compare the sensitivity and specificity of fecal H. pylori gastric cancer susceptibility testing and questionnaire screening for gastric cancer.

    2 years

Secondary Outcomes (3)

  • Positive and negative predictive values of fecal H. pylori gastric cancer susceptibility testing and questionnaire screening for gastric cancer

    2 years

  • Number needed to screen to identify one gastric cancer

    2 years

  • Early diagnosis rate of gastric cancer

    2 years

Interventions

In the early stage of the study, the team used genome-wide association analysis (GWAS) to identify H. pylori specific SNP that are significantly associated with gastric cancer in gastric cancer patients and controls; according to the mutation or not of the SNP loci, the strains were categorized into the high-risk group of gastric cancer and the low-risk group. The status of the SNP locus was detected in portable and non-invasive fecal samples from participants using molecular biology assays for early non-invasive screening and risk assessment of gastric cancer in H. pylori infected patients.

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Subjects were recruited mainly from communities in Tongling, Anhui Province. The subjects were identified by the investigator based on the enrollment criteria and were informed about the contents of the informed consent form.

You may qualify if:

  • Age ≥40 years, male or female.
  • No contraindications to endoscopy and able to cooperate with endoscopy.
  • Patients must be able to fully understand the informed consent form and be able to sign the informed consent form in person.

You may not qualify if:

  • A history of diagnosed gastric cancer or other malignant tumors of the digestive tract.
  • Comorbid severe underlying conditions (e.g., severe cardiopulmonary insufficiency, liver or renal failure, etc.) that are likely to result in a short life expectancy or render long-term follow-up impractical.
  • Severe mental illness or incapacity to participate in the study due to lack of civil behavior.
  • Pregnant or breastfeeding women.
  • Other conditions that the investigator deems inappropriate for participation in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

People's Hospital of Tongling City

Tongling, China

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Feces

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of the gastric surgery department

Study Record Dates

First Submitted

March 17, 2025

First Posted

April 24, 2025

Study Start

July 1, 2025

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

February 25, 2026

Record last verified: 2026-02

Locations